These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 28078787)
1. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress. Li Q; Ni W; Deng Z; Liu M; She L; Xie Q Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787 [TBL] [Abstract][Full Text] [Related]
2. Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway. Lin YT; Wang HC; Hsu YC; Cho CL; Yang MY; Chien CY Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644386 [TBL] [Abstract][Full Text] [Related]
3. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling. Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529 [TBL] [Abstract][Full Text] [Related]
4. Expression and functional implications of YME1L in nasopharyngeal carcinoma. Cheng F; Huang H; Yin S; Liu JS; Sun P Cell Death Dis; 2024 Jun; 15(6):423. PubMed ID: 38890304 [TBL] [Abstract][Full Text] [Related]
5. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway. ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509 [TBL] [Abstract][Full Text] [Related]
6. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682 [TBL] [Abstract][Full Text] [Related]
7. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma. Liu T; Sun Q; Li Q; Yang H; Zhang Y; Wang R; Lin X; Xiao D; Yuan Y; Chen L; Wang W Mol Cancer Ther; 2015 Feb; 14(2):429-39. PubMed ID: 25504751 [TBL] [Abstract][Full Text] [Related]
8. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis. Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523 [TBL] [Abstract][Full Text] [Related]
9. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway. Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells. Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183 [TBL] [Abstract][Full Text] [Related]
11. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma. Wang W; Wen Q; Xu L; Xie G; Li J; Luo J; Chu S; Shi L; Huang D; Li J; Fan S PLoS One; 2014; 9(8):e106098. PubMed ID: 25165983 [TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway. Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143 [TBL] [Abstract][Full Text] [Related]
13. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612 [TBL] [Abstract][Full Text] [Related]
14. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway. Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380 [TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma. Zhang J; Jiang Y; Yu Y; Li J Eur J Pharmacol; 2022 Jan; 915():174688. PubMed ID: 34883074 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway. Li H; Jiao S; Li X; Banu H; Hamal S; Wang X Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748 [TBL] [Abstract][Full Text] [Related]
17. Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition. Xiao Q; Yang L; Hu H; Ke Y J Bioenerg Biomembr; 2020 Apr; 52(2):113-121. PubMed ID: 31965456 [TBL] [Abstract][Full Text] [Related]